Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1994 Oct;71(4):285–287. doi: 10.1136/adc.71.4.285

Treatment of the short, sexually immature adolescent boy.

C J Kelnar
PMCID: PMC1030002  PMID: 7979517

Full text

PDF
285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albanese A., Kewley G. D., Long A., Pearl K. N., Robins D. G., Stanhope R. Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate. Arch Dis Child. 1994 Oct;71(4):315–317. doi: 10.1136/adc.71.4.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Butler G. E., Sellar R. E., Walker R. F., Hendry M., Kelnar C. J., Wu F. C. Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth. J Clin Endocrinol Metab. 1992 Jul;75(1):37–44. doi: 10.1210/jcem.75.1.1619029. [DOI] [PubMed] [Google Scholar]
  3. Crowne E. C., Shalet S. M., Wallace W. H., Eminson D. M., Price D. A. Final height in boys with untreated constitutional delay in growth and puberty. Arch Dis Child. 1990 Oct;65(10):1109–1112. doi: 10.1136/adc.65.10.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Finkelstein J. S., Neer R. M., Biller B. M., Crawford J. D., Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med. 1992 Feb 27;326(9):600–604. doi: 10.1056/NEJM199202273260904. [DOI] [PubMed] [Google Scholar]
  5. Geere G., Jones J., Atherden S. M., Grant D. B. Plasma androgens after a single oral dose of testosterone undecanoate. Arch Dis Child. 1980 Mar;55(3):218–220. doi: 10.1136/adc.55.3.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kelnar C. J. Pride and prejudice--stature in perspective. Acta Paediatr Scand Suppl. 1990;370:5–15. doi: 10.1111/j.1651-2227.1990.tb11662.x. [DOI] [PubMed] [Google Scholar]
  7. Stanhope R., Brook C. G. Oxandrolone in low dose for constitutional delay of growth and puberty in boys. Arch Dis Child. 1985 Apr;60(4):379–381. doi: 10.1136/adc.60.4.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Stanhope R., Buchanan C. R., Fenn G. C., Preece M. A. Double blind placebo controlled trial of low dose oxandrolone in the treatment of boys with constitutional delay of growth and puberty. Arch Dis Child. 1988 May;63(5):501–505. doi: 10.1136/adc.63.5.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wu F. C., Butler G. E., Kelnar C. J., Sellar R. E. Patterns of pulsatile luteinizing hormone secretion before and during the onset of puberty in boys: a study using an immunoradiometric assay. J Clin Endocrinol Metab. 1990 Mar;70(3):629–637. doi: 10.1210/jcem-70-3-629. [DOI] [PubMed] [Google Scholar]
  10. Wu F. C., Butler G. E., Kelnar C. J., Stirling H. F., Huhtaniemi I. Patterns of pulsatile luteinizing hormone and follicle-stimulating hormone secretion in prepubertal (midchildhood) boys and girls and patients with idiopathic hypogonadotropic hypogonadism (Kallmann's syndrome): a study using an ultrasensitive time-resolved immunofluorometric assay. J Clin Endocrinol Metab. 1991 Jun;72(6):1229–1237. doi: 10.1210/jcem-72-6-1229. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES